In drug-resistant esophageal cancer cells, luteolin functions to suppress the FAK/PI3K/AKT pathway, thereby sensitizing them to chemotherapeutic agents (Yang et al., 2024). This evidence concerns the gene PTK2 and esophageal cancer.